Aust B, Helverskov T, Nielsen MB, Bjorner JB, Rugulies R, Nielsen K, Sørensen OH, Grundtvig G, Andersen MF, Hansen JV, Buchardt HL, Nielsen L, Lund TL, Andersen I, Andersen MH, Clausen AS, Heinesen E, Mortensen OS, Ektor-Andersen J, Ørbæk P, Winzor G, Bültmann U, Poulsen OM.

Scand J Work Environ Health. 2012 Mar;38(2):120-33. doi: 10.5271/sjweh.3272. Epub 2012 Jan 13.

PMID:: 22245919

Free Article

Similar articles

Select item 204843066.

Persistence to medical treatment of osteoporosis in women at three different clinical settings--a historical cohort study.

Nielsen DS, Langdahl BL, Sørensen OH, Sørensen HA, Brixen KT.

Scand J Public Health. 2010 Jul;38(5):502-7. doi: 10.1177/1403494810371243. Epub 2010 May 19.

PMID:: 20484306

Similar articles

Select item 165983737.

Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors.

Roux C, Reginster JY, Fechtenbaum J, Kolta S, Sawicki A, Tulassay Z, Luisetto G, Padrino JM, Doyle D, Prince R, Fardellone P, Sorensen OH, Meunier PJ.

J Bone Miner Res. 2006 Apr;21(4):536-42. Epub 2006 Apr 5.

PMID:: 16598373

Free Article

Similar articles

Select item 161097898.

The antiarrhythmic peptide analog rotigaptide (ZP123) stimulates gap junction intercellular communication in human osteoblasts and prevents decrease in femoral trabecular bone strength in ovariectomized rats.

Jørgensen NR, Teilmann SC, Henriksen Z, Meier E, Hansen SS, Jensen JE, Sørensen OH, Petersen JS.

Endocrinology. 2005 Nov;146(11):4745-54. Epub 2005 Aug 18.

PMID:: 16109789

Similar articles

Select item 157898399.

[Normal ranges and quality assurance for dual energy X-ray absorptiometry scanning].

Abrahamsen B, Sørensen HA, Rud B, Hermann AP, Jensen JE, Mølgaard C, Sørensen OH.

Ugeskr Laeger. 2005 Feb 21;167(8):878-82. Review. Danish. No abstract available.

PMID:: 15789839

Similar articles

Select item 1572821010.

Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study.

Reginster JY, Seeman E, De Vernejoul MC, Adami S, Compston J, Phenekos C, Devogelaer JP, Curiel MD, Sawicki A, Goemaere S, Sorensen OH, Felsenberg D, Meunier PJ.

J Clin Endocrinol Metab. 2005 May;90(5):2816-22. Epub 2005 Feb 22.

PMID:: 15728210

Free Article

Similar articles

Select item 1545518811.

Seven years of treatment with risedronate in women with postmenopausal osteoporosis.

Mellström DD, Sörensen OH, Goemaere S, Roux C, Johnson TD, Chines AA.

Calcif Tissue Int. 2004 Dec;75(6):462-8. Epub 2004 Oct 7.

PMID:: 15455188

Similar articles

Select item 1529309312.

Bone status in rheumatoid arthritis assessed at peripheral sites by three different quantitative ultrasound devices.

Madsen OR, Suetta C, Egsmose C, Lorentzen JS, Sørensen OH.

Clin Rheumatol. 2004 Aug;23(4):324-9. Epub 2004 May 18.

PMID:: 15293093

Similar articles

Select item 1518368713.

Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts.

Jørgensen NR, Henriksen Z, Sørensen OH, Civitelli R.

Steroids. 2004 Apr;69(4):219-26.

PMID:: 15183687

Similar articles

Select item 1455938314.

Effects of 5 years of hormonal replacement therapy on menopausal symptoms and blood pressure-a randomised controlled study.

Vestergaard P, Hermann AP, Stilgren L, Tofteng CL, Sørensen OH, Eiken P, Nielsen SP, Mosekilde L.

Maturitas. 2003 Oct 20;46(2):123-32.

PMID:: 14559383

Similar articles

Select item 1279423015.

Standardization of BMD T-Scores in the first five years after the menopause: do femoral neck-equivalent and older normative range T-Scores improve diagnostic agreement?

Abrahamsen B, Tofteng CL, Bärenholdt O, Vestergaard P, Stilgren LS, Beck-Nielsen H, Nielsen SP, Sørensen OH, Mosekilde L; Danish Osteoporosis Prevention Study.

J Clin Densitom. 2003 Summer;6(2):87-95.

PMID:: 12794230

Similar articles

Select item 1263378316.

Long-term efficacy of risedronate: a 5-year placebo-controlled clinical experience.

Sorensen OH, Crawford GM, Mulder H, Hosking DJ, Gennari C, Mellstrom D, Pack S, Wenderoth D, Cooper C, Reginster JY.

Bone. 2003 Feb;32(2):120-6.

PMID:: 12633783

Similar articles

Select item 1256841117.

Hormone replacement therapy dissociates fat mass and bone mass, and tends to reduce weight gain in early postmenopausal women: a randomized controlled 5-year clinical trial of the Danish Osteoporosis Prevention Study.

Jensen LB, Vestergaard P, Hermann AP, Gram J, Eiken P, Abrahamsen B, Brot C, Kolthoff N, Sørensen OH, Beck-Nielsen H, Nielsen SP, Charles P, Mosekilde L.

J Bone Miner Res. 2003 Feb;18(2):333-42.